siRNA therapy reduces triglycerides in individuals along with uncommon ailment

.RESEARCH FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts by 80% as well as decreased the risk of pancreatitis in patients along with persistent chylomicronemia, along with or even without a genetic diagnosis.